Tango Therapeutics Inc (TNGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 11,607 | 19,875 | 6,471 | 5,431 | 10,732 |
| Gross Profit | 11,607 | 19,875 | 6,471 | 5,431 | 10,732 |
| Operating Expenses | 44,485 | 49,427 | 48,726 | 40,445 | 36,358 |
| Operating Income | -32,878 | -29,552 | -42,255 | -35,014 | -25,626 |
| Other Income | 3,765 | 4,066 | 4,381 | 4,298 | 3,386 |
| Pre-tax Income | -29,113 | -25,486 | -37,874 | -30,716 | -22,240 |
| Income Tax | 54 | 65 | 40 | 47 | 23 |
| Net Income Continuous | -29,167 | -25,551 | -37,914 | -30,763 | -22,263 |
| Net Income | $-29,167 | $-25,551 | $-37,914 | $-30,763 | $-22,263 |
| EPS Basic Total Ops | -0.27 | -0.24 | -0.35 | -0.30 | -0.23 |
| EPS Basic Continuous Ops | -0.27 | -0.24 | -0.35 | -0.29 | -0.23 |
| EPS Diluted Total Ops | -0.27 | -0.24 | -0.35 | -0.30 | -0.23 |
| EPS Diluted Continuous Ops | -0.27 | -0.24 | -0.35 | -0.29 | -0.23 |
| EPS Diluted Before Non-Recurring Items | -0.27 | -0.24 | -0.35 | N/A | N/A |
| EBITDA(a) | $-33,442 | $-30,124 | $-43,001 | $-36,761 | $-24,274 |